Jordan Johnson/LinkedIn
Nov 5, 2024, 00:20
Jordan Johnson: Strong work by Bridge Oncology on the OTV
Jordan Johnson posted the following on X:
“Strong work by Bridge Oncology and others on the OTV. There is much more in Final Rule and to come. Hospitals saw a near 3% increase while MPFS saw a 2.8% cut. See hospital impact here: SBRT, IMRT and 3D. More to come in Monday’s Newsletter and Webinar Next week.”
Jordan Johnson is the Founding Partner of Bridge Oncology and serves on the Board of Directors for the National Association of Medication Access and Patient Advocacy. He is also the Founder of The Healthcare Hub and LegacybyImpact.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12